Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Evaluation of the potential renal transplant recipient

Ana P Rossi, MD, MPH
Christina L Klein, MD
Section Editors
Barbara Murphy, MB, BAO, BCh, FRCPI
Daniel C Brennan, MD, FACP
Deputy Editor
Albert Q Lam, MD


Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD) [1,2]. A successful kidney transplant improves quality of life and reduces the mortality risk for the majority of patients when compared with maintenance dialysis.

Patients with ESRD often have significant comorbidities. It is important that potential kidney transplant recipients are carefully evaluated in order to detect and treat coexisting illnesses, which may affect perioperative risk and survival after transplantation, as well as transplant candidacy [3,4]. (See "Patient survival after renal transplantation".) The evaluation should be as efficient and cost effective as possible.

This topic will review the evaluation of a potential renal transplant recipient. The evaluation of the renal transplant donor is discussed separately. (See "Evaluation of the living kidney donor candidate".)

Issues related to patient survival following transplantation, risk factors associated with graft failure, and the kidney transplant waitlist are discussed elsewhere. (See "Patient survival after renal transplantation" and "Risk factors for graft failure in kidney transplantation" and "The kidney transplant waiting list in the United States".)


Transplantation should be discussed with all patients with irreversible and progressive chronic kidney disease (CKD).

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 10, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331:365.
  2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725.
  3. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12:2753.
  4. Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 2001; 1 Suppl 2:3.
  5. Bunnapradist S, Danovitch GM. Evaluation of adult kidney transplant candidates. Am J Kidney Dis 2007; 50:890.
  6. Ojo A, Wolfe RA, Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 1998; 66:1651.
  7. Ishani A, Ibrahim HN, Gilbertson D, Collins AJ. The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis 2003; 42:1275.
  8. Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 2005; 173:1181.
  9. Kasiske BL, Ramos EL, Gaston RS, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1995; 6:1.
  10. Steinman TI, Becker BN, Frost AE, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 2001; 71:1189.
  11. Abbud-Filho M, Adams PL, Alberú J, et al. A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation 2007; 83:S1.
  12. Barry JM. Kidney transplantation into patients with abnormal bladders. Transplantation 2004; 77:1120.
  13. Harrison EM, Oniscu GC, Forsythe JL. Equity of access to kidney transplantation: to what extent should international guidelines differ? Transplantation 2012; 94:669.
  14. McKay DB, Milford EL, Sayegh MH. Clinical aspects of renal transplantation. In: The Kidney, 5th ed, Brenner BM, Rector FC (Eds), Saunders, Philadelphia 1995.
  15. Evaluation of potential renal transplantation. In: Handbook of Kidney Transplantation, 4th ed., Danovitch GM (Ed), Lippincott, Williams & Wilkins, Philadelphia 2005.
  16. Abramowicz D, Cochat P, Claas FH, et al. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 2015; 30:1790.
  17. Batabyal P, Chapman JR, Wong G, et al. Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation 2012; 94:703.
  18. Ismail N, Hakim RM, Helderman JH. Renal replacement therapies in the elderly: Part II. Renal transplantation. Am J Kidney Dis 1994; 23:1.
  19. Scientific Registry of Transplant Recipients (SRTR) 2012 Annual Data Report http://srtr.transplant.hrsa.gov/annual_reports/2012/ (Accessed on January 15, 2015).
  20. Vivas CA, Hickey DP, Jordan ML, et al. Renal transplantation in patients 65 years old or older. J Urol 1992; 147:990.
  21. Tapson JS, Rodger RS, Mansy H, et al. Renal replacement therapy in patients aged over 60 years. Postgrad Med J 1987; 63:1071.
  22. Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol 2010; 5:1114.
  23. Pilmore H, Dent H, Chang S, et al. Reduction in cardiovascular death after kidney transplantation. Transplantation 2010; 89:851.
  24. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2012; 60:434.
  25. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16:496.
  26. Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006; 17:900.
  27. Gill JS, Ma I, Landsberg D, et al. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol 2005; 16:808.
  28. Col VJ, Jacquet L, Squifflet JP, et al. Combined heart-kidney transplantation: report on six cases. Nephrol Dial Transplant 1998; 13:723.
  29. Kocher AA, Schlechta B, Kopp CW, et al. Combined heart and kidney transplantation using a single donor: a single center's experience with nine cases. Transplantation 1998; 66:1760.
  30. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005; 80:815.
  31. Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int 2015; 87:527.
  32. De Lima JJ, Sabbaga E, Vieira ML, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42:263.
  33. Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant 2006; 6:659.
  34. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90:563.
  35. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1.
  36. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368:987.
  37. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007; 109:1878.
  38. Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev 2011; :CD008691.
  39. Winther S, Bøttcher M, Jørgensen HS, et al. Coronary Calcium Score May Replace Cardiovascular Risk Factors as Primary Risk Stratification Tool Before Kidney Transplantation. Transplantation 2016; 100:2177.
  40. Patel RK, Pennington C, Stevens KK, et al. Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study. Transplant Res 2014; 3:20.
  41. Kainz A, Goliasch G, Wiesbauer F, et al. Left atrial diameter and survival among renal allograft recipients. Clin J Am Soc Nephrol 2013; 8:2100.
  42. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363:2004.
  43. Chen KJ, Chen CH, Cheng CH, et al. Risk factors for peptic ulcer disease in renal transplant patients--11 years of experience from a single center. Clin Nephrol 2004; 62:14.
  44. Lowell JA, Stratta RJ, Taylor RJ, et al. Cholelithiasis in pancreas and kidney transplant recipients with diabetes. Surgery 1993; 114:858.
  45. Kao LS, Flowers C, Flum DR. Prophylactic cholecystectomy in transplant patients: a decision analysis. J Gastrointest Surg 2005; 9:965.
  46. Meka M, Potdar S, Benotti P, et al. Role of ultrasound screening for gallbladder disease in pretransplant patients. Am Surg 2008; 74:832.
  47. Adams HP Jr, Dawson G, Coffman TJ, Corry RJ. Stroke in renal transplant recipients. Arch Neurol 1986; 43:113.
  48. Sung RS, Althoen M, Howell TA, Merion RM. Peripheral vascular occlusive disease in renal transplant recipients: risk factors and impact on kidney allograft survival. Transplantation 2000; 70:1049.
  49. Snyder JJ, Kasiske BL, Maclean R. Peripheral arterial disease and renal transplantation. J Am Soc Nephrol 2006; 17:2056.
  50. Mäkisalo H, Lepäntalo M, Halme L, et al. Peripheral arterial disease as a predictor of outcome after renal transplantation. Transpl Int 1998; 11 Suppl 1:S140.
  51. Smetana GW. Preoperative pulmonary evaluation. N Engl J Med 1999; 340:937.
  52. Ferguson GT. Recommendations for the management of COPD. Chest 2000; 117:23S.
  53. Issa N, Krowka MJ, Griffin MD, et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008; 86:1384.
  54. Kasiske BL, Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 2000; 11:753.
  55. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354:93.
  56. Gulanikar AC, Daily PP, Kilambi NK, et al. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation 1998; 66:1669.
  57. Chapman JR, Sheil AG, Disney AP. Recurrence of cancer after renal transplantation. Transplant Proc 2001; 33:1830.
  58. Barrett WL, First MR, Aron BS, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72:2186.
  59. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55:742.
  60. Trofe J, Buell JF, Woodle ES, et al. Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation 2004; 78:972.
  61. Power RE, Hickey DP, Little DM. Urological evaluation prior to renal transplantation. Transplant Proc 2004; 36:2962.
  62. Legendre CM, Licht C, Muus P, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013; 368:2169.
  63. Rathbone J, Kaltenthaler E, Richards A, et al. A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS). BMJ Open 2013; 3:e003573.
  64. Nicoletto BB, Fonseca NK, Manfro RC, et al. Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis. Transplantation 2014; 98:167.
  65. Scandling JD. Kidney transplant candidate evaluation. Semin Dial 2005; 18:487.
  66. Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics 1993; 34:314.
  67. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009; 87:1497.
  68. Garonzik-Wang JM, Govindan P, Grinnan JW, et al. Frailty and delayed graft function in kidney transplant recipients. Arch Surg 2012; 147:190.
  69. McAdams-DeMarco MA, Law A, Salter ML, et al. Frailty and early hospital readmission after kidney transplantation. Am J Transplant 2013; 13:2091.
  70. McAdams-DeMarco MA, Law A, King E, et al. Frailty and mortality in kidney transplant recipients. Am J Transplant 2015; 15:149.
  71. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146.
  72. Redfield RR, Gupta M, Rodriguez E, et al. Graft and patient survival outcomes of a third kidney transplant. Transplantation 2015; 99:416.
  73. Striegel JE, Sibley RK, Fryd DS, Mauer SM. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int Suppl 1986; 19:S44.
  74. Lewis EJ. Recurrent focal sclerosis after renal transplantation. Kidney Int 1982; 22:315.
  75. Ramos EL. Recurrent diseases in the renal allograft. J Am Soc Nephrol 1991; 2:109.
  76. Ramos EL, Tisher CC. Recurrent diseases in the kidney transplant. Am J Kidney Dis 1994; 24:142.
  77. Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68:635.
  78. Briggs JD, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14:564.
  79. Goldfarb DA, Neumann HP, Penn I, Novick AC. Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation 1997; 64:1726.
  80. Brazda E, Ofner D, Riedmann B, et al. The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann Transplant 1996; 1:15.
  81. Knispel HH, Klän R, Offermann G, Miller K. Transplantation in autosomal dominant polycystic kidney disease without nephrectomy. Urol Int 1996; 56:75.
  82. Wagner MD, Prather JC, Barry JM. Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease. J Urol 2007; 177:2250.
  83. Erturk E, Burzon DT, Orloff M, Rabinowitz R. Outcome of patients with vesicoureteral reflux after renal transplantation: the effect of pretransplantation surgery on posttransplant urinary tract infections. Urology 1998; 51:27.
  84. Savage JM, Jefferson JA, Maxwell AP, et al. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families. Arch Dis Child 1999; 80:466.
  85. Slaughenhoupt BL, Lohrasbi FF, Harrison HL, Van Savage JG. Urologic management of congenital nephrotic syndrome of the Finnish type. Urology 1998; 51:492.